BioCentury

7:00 AM GMT, May 28, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Finance

Amgen's balance sheet shuffle

Amgen's balance sheet shuffle

Last week, Amgen (AMGN) sold $4 billion in notes, saying it plans to use $3 billion of the proceeds to buy back shares.

Read the full 261 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.